首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

市場調查報告書

商品編碼

1498657

全球太空轉錄組學市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Spatial Transcriptomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球空間轉錄組學市場需求預計將從 2023 年的 3.8397 億美元增至 2032 年的近 13.3602 億美元，2024-2032 年研究期間複合年成長率為 14.86%。

空間轉錄組學是一種先進的技術，它將組織學與轉錄組學結合，分析組織切片空間背景下的基因表現。這種方法使研究人員能夠繪製複雜組織中活性基因的位置圖，從而深入了解細胞功能、相互作用和微環境。保留空間資訊有助於了解組織結構、識別不同的細胞生態位以及在粒度層面上研究疾病病理學。該技術在腫瘤學、神經科學和發育生物學方面具有重要應用，可在理解基因表現如何隨組織區域變化方面取得突破。

市場動態

空間轉錄組學市場正在受到塑造其成長軌蹟的幾個影響因素的推動。首先，基因組定序技術和生物資訊學的進步徹底改變了轉錄組學領域，使研究人員能夠研究組織和器官空間背景下的基因表現模式。這種空間解析的轉錄組資料為細胞相互作用、組織結構和疾病機制提供了寶貴的見解，推動了市場成長。單細胞分析技術和空間分辨成像模式（例如多重螢光原位雜合技術 (FISH) 和空間轉錄組學檢測）的日益普及，增強了研究人員以前所未有的解析度和規模探索複雜生物系統的能力。他們還增加了研究投資和資助計劃，透過支持創新和產品開發來了解健康和疾病燃料市場擴張中的空間基因表現動態。

此外，該技術在腫瘤學、神經科學、發育生物學和免疫學等各個領域的應用不斷增加，擴大了市場機會，並推動了學術機構、生物技術公司和製藥公司之間的跨學科合作。此外，空間轉錄組學資料與其他組學資料集（例如基因組學、蛋白質組學和代謝組學）的整合有望實現全面的系統生物學方法和個人化醫療策略，從而推動市場進一步成長。然而，高昂的技術成本和對專業知識的需求可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球空間轉錄組市場的每個細分市場進行了包容性評估。空間轉錄組學產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

空間轉錄組學市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

耗材
儀器
服務

按申請

臨床
藥物和生物標記的發現和開發

按最終用戶

學術機構
臨床與生命科學實驗室
製藥和生物技術公司
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲空間轉錄組學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。空間轉錄組學市場的主要參與者包括 10x Genomics Inc.、NanoString Technologies Inc.、Akoya Biosciences Inc.、Bio-Techne Corporation、Bruker Corporation、Standard BioTools Inc. (Fluidigm)、Vizgen Inc.。競爭格局，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：空間轉錄組學公司的競爭格局

空間轉錄組學市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
10x Genomics Inc.

公司簡介
公司收入
產品
最近的發展

NanoString Technologies Inc.

公司簡介
公司收入
產品
最近的發展

Akoya Biosciences Inc.

公司簡介
公司收入
產品
最近的發展

Bio-Techne Corporation

公司簡介
公司收入
產品
最近的發展

Bruker Corporation

公司簡介
公司收入
產品
最近的發展

Standard BioTools Inc. (Fluidigm)

公司簡介
公司收入
產品
最近的發展

Vizgen Inc

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114767

The global demand for Spatial Transcriptomics Market is presumed to reach the market size of nearly USD 1336.02 Million by 2032 from USD 383.97 Million in 2023 with a CAGR of 14.86% under the study period 2024-2032.

Spatial transcriptomics is an advanced technique that combines histology with transcriptomics to analyze gene expression within the spatial context of tissue sections. This method allows researchers to map the location of active genes in complex tissues, providing insights into cellular functions, interactions, and the microenvironment. Preserving spatial information helps to understand tissue architecture, identify distinct cellular niches, and study disease pathology at a granular level. This technology has significant applications in oncology, neuroscience, and developmental biology, enabling breakthroughs in understanding how gene expression varies across tissue regions.

MARKET DYNAMICS

The spatial transcriptomics market is being propelled by several influential factors shaping its growth trajectory. Firstly, advancements in genomic sequencing technologies and bioinformatics have revolutionized the field of transcriptomics, enabling researchers to study gene expression patterns within the spatial context of tissues and organs. This spatially resolved transcriptomic data provides valuable insights into cellular interactions, tissue architecture, and disease mechanisms, driving market growth. The growing adoption of single-cell analysis techniques and spatially resolved imaging modalities, such as multiplexed fluorescence in situ hybridization (FISH) and spatial transcriptomicsassays, enhances researchers' ability to explore complex biological systems at unprecedented resolution and scale. They are additionally increasing research investments and funding initiatives to understand spatial gene expression dynamics in health and disease fuel market expansion by supporting innovation and product development.

Moreover, rising applications of this technique in various fields, including oncology, neuroscience, developmental biology, and immunology, broaden market opportunities and drive interdisciplinary collaborations among academic institutions, biotechnology companies, and pharmaceutical firms. Furthermore, the integration of spatial transcriptomics data with other omics datasets, such as genomics, proteomics, and metabolomics, holds promise for comprehensive systems biology approaches and personalized medicine strategies, driving further market growth. However, the high cost of technology and the need for specialized expertise may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Spatial Transcriptomics. The growth and trends of Spatial Transcriptomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Spatial Transcriptomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Consumables
Instruments
Services

By Application

Clinical
Drug and Biomarker Discovery and Development

By End-user

Academic Institutes
Clinical and Life Science Laboratories
Pharmaceutical and Biotechnology Companies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Spatial Transcriptomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Spatial Transcriptomics market include 10x Genomics Inc., NanoString Technologies Inc., Akoya Biosciences Inc., Bio-Techne Corporation, Bruker Corporation, Standard BioTools Inc. (Fluidigm), Vizgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. SPATIAL TRANSCRIPTOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Consumables Historic and Forecast Sales By Regions
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Clinical Historic and Forecast Sales By Regions
6.4. Drug and Biomarker Discovery and Development Historic and Forecast Sales By Regions

7. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Academic Institutes Historic and Forecast Sales By Regions
7.4. Clinical and Life Science Laboratories Historic and Forecast Sales By Regions
7.5. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SPATIAL TRANSCRIPTOMICS COMPANIES

9.1. Spatial Transcriptomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF SPATIAL TRANSCRIPTOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. 10x Genomics Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. NanoString Technologies Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Akoya Biosciences Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio-Techne Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Bruker Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Standard BioTools Inc. (Fluidigm)
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Vizgen Inc
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments